Alpha DNA Investment Management’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,344
Closed -$550K 202
2023
Q3
$550K Buy
+19,344
New +$522K 0.22% 113
2022
Q3
Sell
-34,946
Closed -$902K 163
2022
Q2
$902K Buy
+34,946
New +$943K 0.77% 100

Other funds holding DK

Alpha DNA Investment Management's DK Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Delek US (DK) in Q4 2023, closing a stake of 19,344 shares — an estimated $550K sold.

Alpha DNA Investment Management first reported a position in DK in Q2 2022 and held it in 2 quarters. The position peaked at $902K in Q2 2022. 221 funds tracked by Wall St. Rank hold DK as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Delek US position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 19,344 Delek US shares in Q4 2023, an estimated $550K.
  • Alpha DNA Investment Management first reported a position in Delek US in Q2 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Delek US position peaked at $902K in Q2 2022.
  • 221 funds tracked by Wall St. Rank held Delek US as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.